Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100
Holland receives NCI Outstanding Investigator Award

Holland receives NCI Outstanding Investigator Award

Neuroscientist will tackle genetic abnormalities that drive cancers and could be therapeutic targets
Hutch News - October 29, 2021
Using AI to identify potential COVID-19, cancer therapies

Using AI to identify potential COVID-19, cancer therapies

Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Hutch News - September 30, 2021
YAP1 gene fusions are oncogenic drivers in several tumor types and potential therapeutic targets

YAP1 gene fusions are oncogenic drivers in several tumor types and potential therapeutic targets

From the Holland, Paddison, Vasioukhin, and Gujral labs, Human Biology Division
Science Spotlight - September 21, 2020
New study shows cancer-causing ‘Frankengene’ mutation could be target for new drugs

New study shows cancer-causing ‘Frankengene’ mutation could be target for new drugs

This gene is fused to many partner genes in different tumors. Now, scientists know it causes cancer — and how they might intervene
Hutch News - July 16, 2020
Fred Hutch–led team receives $6M to study deadly brain tumor

Fred Hutch–led team receives $6M to study deadly brain tumor

Researchers seek deeper understanding of ependymoma biology to aid treatment discovery
Hutch News - October 10, 2019
Bringing personalized oncology to cancer prediction — and prevention

Bringing personalized oncology to cancer prediction — and prevention

Unique $2.4M NCI-NIEHS award teams Hutch cancer geneticists, epidemiologists and oncologists to use mutation rate to predict individual cancer risk
Hutch News - October 01, 2018
Brain cancer subtype caused by single gene fusion

Brain cancer subtype caused by single gene fusion

Hutch researchers create genetically relevant model to examine the biology of supratentorial ependymomas
Hutch News - June 26, 2018
Nanoparticles take immunotherapy in new direction

Nanoparticles take immunotherapy in new direction

Hutch scientist to use nanoparticles to reprogram macrophages to tackle brain tumors
Hutch News - May 30, 2018
Study sheds light on why brain cancers become aggressive and treatment-resistant

Study sheds light on why brain cancers become aggressive and treatment-resistant

New computational method sheds light on how cancer-contributing genes make brain tumors more aggressive and radiation-resistant
Hutch News - April 13, 2018
Single gene alters immune response to deadly brain cancer

Single gene alters immune response to deadly brain cancer

A new study of glioma in humans and mice links more aggressive immune response to poorer prognosis
Hutch News - May 23, 2017
Last Modified, April 02, 2020